APREA THERAPEUTICS INC (APRE:NASDAQ)

$0.6044 0.0462 (8.2766%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 83

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed APREA THERAPEUTICS INC (APRE:NASDAQ) News Sources

Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

21-04-2026

yahoo.com

Aprea Therapeutics Announces Closing of Oversubscribed $30 Million Private Placement

01-04-2026

yahoo.com

Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

13-05-2026

yahoo.com

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

01-06-2026

yahoo.com

Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026

30-07-2026

yahoo.com

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

12-08-2026

yahoo.com

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

28-08-2026

yahoo.com

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

10-09-2026

yahoo.com

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

22-09-2026

yahoo.com

Aprea Therapeutics to Present at October Conferences

05-10-2026

yahoo.com

APREA THERAPEUTICS INC (APRE:NASDAQ) Sentiment Trend

0 25 50 75 100 85 69 80 85 88 84 84 86 85 87 21-04-2026 01-04-2026 13-05-2026 01-06-2026 30-07-2026 12-08-2026 28-08-2026 10-09-2026 22-09-2026 05-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

APREA THERAPEUTICS INC (APRE:NASDAQ) FAQs

toggle

What is the current price of APREA THERAPEUTICS INC (APRE:NASDAQ)?

The current price of APREA THERAPEUTICS INC (APRE:NASDAQ) is $0.6044.


toggle

APREA THERAPEUTICS INC (APRE:NASDAQ) absolute price change since previous trading day?

The absolute price change of APREA THERAPEUTICS INC (APRE:NASDAQ) since the previous trading day is $0.0462.


toggle

APREA THERAPEUTICS INC (APRE:NASDAQ) percentage price change since previous trading day?

The percentage price change of APREA THERAPEUTICS INC (APRE:NASDAQ) since the previous trading day is 8.2766%.


toggle

What is the most recent average sentiment score for APREA THERAPEUTICS INC (APRE:NASDAQ)?

The most recent average sentiment score for APREA THERAPEUTICS INC (APRE:NASDAQ) is 83 out of 100.


toggle

What is the most recent average sentiment for APREA THERAPEUTICS INC (APRE:NASDAQ)?

The most recent sentiment for APREA THERAPEUTICS INC (APRE:NASDAQ) is .


SEC-8K** Filing Available For APREA THERAPEUTICS INC (APRE:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.